The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion
Authors:
- 1 July 2002
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 134 (1) , 57-61
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Low Folate Levels and Thermolabile Methylenetetrahydrofolate Reductase as Primary Determinant of Mild Hyperhomocystinemia in Normal and Thromboembolic SubjectsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: Implications for increased vascular riskEye, 1998
- Homocysteine and Cardiovascular DiseaseAnnual Review of Medicine, 1998
- The 677C→T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic diseaseAtherosclerosis, 1997
- Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1997
- Vitamins as Homocysteine-Lowering AgentsThe Journal of Nutrition, 1996
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery StenosisNew England Journal of Medicine, 1995
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991